Diabetic macular edema: Current and emerging therapies

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations


Diabetic macular edema is a leading cause of vision impairment among people within the working-age population. This review discusses the pathogenesis of diabetic macular edema and the treatment options currently available for the treatment of diabetic macular edema, including for focal/grid photocoagulation, intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor agents. The biologic rationale for novel therapeutic agents, many of which are currently being evaluated in clinical trials, also is reviewed.

Original languageEnglish (US)
Pages (from-to)4-12
Number of pages9
JournalMiddle East African Journal of Ophthalmology
Issue number1
StatePublished - Jan 2012


  • Diabetic Macular Edema
  • Focal/Grid Photocoagulation
  • Intravitreal Corticosteroids

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Diabetic macular edema: Current and emerging therapies'. Together they form a unique fingerprint.

Cite this